Myelodysplastic syndrome in a case of new‐onset pancytopenia

Abstract

Abstract Myelodysplastic syndrome (MDS) is an infrequent cause of pancytopenia, which is a decrease in all three peripheral blood cell lines. We report the case of new‐onset pancytopenia following administration of a COVID‐19 vaccine and recurrent Zosyn use who was later found to have myelodysplastic syndrome.

Keywords

• myelodysplastic syndrome
• pancytopenia
• piperacillin/tazobactam‐induced immune response
• vaccine‐associated pancytopenia